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INTRODUCTION: 
Carrier technology offers an intelligent approach for drug 
delivery by coupling the drug to a carrier particle such as 
Microspheres[1], nanoparticles, liposomes, etc. which 
modulates the release and absorption characteristics of 
the drug. Dosage forms that can precisely control the 
release rates and target drugs to a specific body site have 
created enormous impact on the formulation and 
development of novel drug delivery systems [2]. 
Controlled drug delivery occurs when a polymer, 
whether natural or synthetic, is judiciously combined 
with a drug or other active agent in such a way that the 
active agent is released from the material in a 
predesigned manner 
[3, 4]
. Microspheres constitute an 
important part of these particulate DDS by virtue of their 
small size and efficient carrier characteristics. 
Microspheres have many applications in medicine, with 
the main uses being for the encapsulation of drugs and 
proteins. Microparticulate systems can be made by 
various techniques involving physicochemical processes 
(solvent evaporation method, phase separation method) 
and mechanical processes (e.g., spray drying) [5]. 
A protein delivery system with high loading capacity is 
very advantageous, because it can prevent the loss of 
antigen and also limit the need of administering high 
level of carrier [6]. Several difficulties are faced in 
designing of microspheres better absorption and 
enhanced bioavailability. The formulation variables have 
a variety of effects on the physicochemical properties of 
the microspheres. The bio-distribution of the drug from 
microspheres is highly dependent on the size and % drug 
entrapment of the microspheres. Release kinetics of the 
microsphere matrix is depend on the various factors i.e. 
type of polymer used [1], concentration of polymer [1, 7-11], 
drug to polymer ratio, solubility of drug, dispersed phase 
to continuous phase ratio etc. These variables directly 
affect the loading efficiency of the microspheres. In 
solvent evaporation method entrapment efficiency of 
water-soluble drugs is low due to drug loss from the 
organic emulsified polymeric phase before solidification 
of polymer in the microspheres [12, 13]. Therefore, process 
optimization and formulation optimization are 
advantageous for the efficient entrapment of water-
soluble labile drugs like therapeutic enzymes. Optimum 
formulation can be made possible by understanding of 
variables which affect the particle size, drug entrapment, 
swelling index, mucoadhesion and drug release of 
microspheres. Purpose of writing this review was to 
compile the recent literature on the various formulation 
variables influencing the characteristics of microspheres. 
Additionally this also summarized the method of 
preparation and characterization of microspheres.  
FACTORS INFLUENCING DRUG ENTRAPMENT 
EFFICIENCY OF MICROSPHERES: 
Deep understanding of effects of some important factors 
and their interactions during the process of preparation 
on Microparticles physicochemical properties are 
necessary before designing and evaluation of 
microspheres. 
ABSTRACT 
Purpose of writing this review on microspheres was to compile the recent literature with special focus on formulation 
variables which affect the drug entrapment efficiency of microspheres. There are various approaches in delivering a 
therapeutic substance to the target site in a controlled release fashion. One such approach is using microspheres as carriers 
for drugs.  Microencapsulation is used to modify and delayed drug release form pharmaceutical dosage forms. For success of 
microspheres as drug delivery system its necessary to obtained desired particle size, maximum drug entrapment, 
mucoadhesion, swelling index and drug release. This can be obtained by optimizing the formulation as well as process 
variables but before designing the microspheres formulation deep understanding the effect of various variables on 
characteristics of microspheres is necessary. The intent of the paper is to highlight the reported study on various formulation 
variables those are might be useful to encountered several problems which is reason for low drug entrapment efficiency.  
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Fig 1: Formulation variables and their effect on 
microspheres (+→ Increase, — →Decrease) 
Concentration of the polymer in dispersed phase: 
Results from different study shows that the particle size, 
swelling, loading efficiency and rate of drug release from 
the microspheres depended on the polymer concentration 
and the type of polymer used. 
Encapsulation efficiency increases with increasing 
polymer concentration [7-9]. For example, the 
encapsulation efficiency increased from 53.1 to 70.9% 
when concentration of the polymer increased from 20.0 to 
32.5% [7]. High viscosity and fast solidification of the 
dispersed phase contributed to reduce porosity of the 
microparticles as well [10]. The contribution of a high 
polymer concentration to the loading efficiency can be 
interpreted in three ways. First, when highly concentrated, 
the polymer precipitates faster on the surface of the 
dispersed phase and prevents drug diffusion across the 
phase boundary [8]. Second, the high concentration 
increases viscosity of the solution and delays the drug 
diffusion within the polymer droplets [11]. Third, the high 
polymer concentration results large size of microspheres 
which result in loss of drug from surface during washing 
of microspheres is very less as compare to small 
microspheres. Thus size of microspheres is also affecting 
the loading efficiency [1]. 
X. Fu et al., studied the effect of molecular weight of the 
polymer on encapsulation efficiency, developed a long-
acting injectable huperzine A-PLGA microsphere for the 
chronic therapy of Alzheimer's disease, the microsphere 
was prepared by using o/w emulsion solvent extraction 
evaporation method. The encapsulation efficiency of the 
microspheres improved as the polymer concentration 
increase in oil phase and PVA concentration decreased in 
aqueous phase. 15 
Thakkar et al investigated the effect of polymer 
concentration on the encapsulation efficiency of the 
Celecoxib Microspheres of natural polymer (bovine serum 
albumin) BSA using emulsification chemical cross-linking 
method. Results from this investigation shows that 
increase in concentration of BSA significantly increase the 
encapsulation efficiency of microspheres. The entrapment 
efficiency increases with an increase in the albumin 
concentration because with an increase in the albumin 
concentration, more viscous solutions are formed that can 
more efficiently prevent the dissolution of Celecoxib in 
the external phase of the emulsion. At a lower 
concentration of albumin, a major amount of the drug 
remained as free drug 16. 
Agrawal et al studied the effects of variables such as 
polymer concentration on the particle size, drug release 
and loading efficiency of microspheres at increasing 
Polymer concentrations (i.e., at drug–Polymer ratios from 
1:2 to 1:6) increased from 135.3 to 163.4 mm. This 
increase in particle size of the microspheres can be 
attributed to an increase in viscosity with increasing 
polymer concentrations, which resulted in larger emulsion 
droplets and finally in greater microsphere Size. The 
release of albendazole from microspheres decreased as the 
Polymer concentration increased, suggesting that drug 
release could be controlled by varying the Polymer 
concentration. The results might also be explained by the 
fact that the higher Polymer content resulted in larger 
particles with proportionately less drug, so that the drug–
polymer ratio was changed and thus release was reduced. 
17 
Another study shown that increase of mean particle size 
with increase in polymer concentration may have occurred 
due to the fact that as polymer concentration increases it 
produces a significant increase in the viscosity in a fixed 
volume of solvent, thus leading to an increase of the 
emulsion droplet size and finally a higher microsphere 
size. 15, 17-27 
The drug entrapment efficiency of microspheres was also 
improved with changing the concentration of drug and 
polymer in the internal phase to the higher concentration. 
This may be due to the increase in the viscosity of the 
internal phase that reduces the migration of the drug 
molecules in the aqueous phase.28 
Results from study by Lakshmana Prabu S et al revealed 
that the drug content of microspheres was not affected by 
the volume of dichloromethane, but the particle sizes were 
found to change significantly. This may also be due to the 
increase in the volume of dichloromethane leads to 
decrease in viscosity of the internal phase could be an 
effective factor in the droplet size of the emulsion in the 
aqueous medium. In this case, it seems that the shear 
effect of the propeller is able to break the large droplets 
into smaller ones, which are solidified into microspheres 
on solvent evaporation. 31 
Drug: Polymer Ratio (DPR): 
The drug entrapment efficiency within microspheres 
produced using the solvent evaporation method is of 
fundamental importance as failure to achieve acceptable 
drug loadings may preclude the use of this method for 
economic reasons 32 Trivedi et al prepared Aceclofenac 
microspheres by emulsion-solvent evaporation method 
using Eudragit RL100, Eudragit RS100 and Eudragit 
S100. Results from this study clearly indicate that 
encapsulation efficiency is significantly increasing as the 
DPR decreased 33. Nagda et al reported that encapsulation 
efficiency of carbopol microspheres significantly increase 
as the amount of polymer is increased at the same amount 
of drug in the dispersed 34.  
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Fig 2: Drug entrapment efficiency of Trimetazidine 
hydrochloride Microspheres 34 
Pavanveena et al prepared trimetazidine hydrochloride 
loaded chitosan microspheres and studied the effect of 
drug: polymer ratio on the loading efficiency of these 
microspheres. Three different formulations with drug: 
polymer ratios (1:1, 1:2, 1:3) are prepared and coded as 
F1, F2 and F3. Figure 2 shows increase the loading 
efficiency as increase in amount polymer while drug 
content keeping constant 35.  
Drug release from microspheres is notably affected by the 
ratio of the drug to the polymer as increasing in the first 
causes faster drug release. By increasing the amount of 
drug loading, a point will be reached when the solid drug 
particles upon dissolution will begin to form continuous 
pores or channels within the matrix. Under these 
circumstances, the path of release for drug molecules will 
be diffusion within the channels formed from areas where 
drug has previously leached out from the matrix 36, 37. In 
other words, as the amount of drug content is increased 
the matrix will become more porous as drug is leached out 
from the polymer and thus faster drug release rate occurs 
38. 
Solubility of polymer in the solvent: 
Mehta et al.7, studied the effect of solubility of different 
PLGAs polymers in methylene chloride were compared 
by measuring the methanol cloud point (Cs): Higher Cs 
meant that the polymer was more soluble in methylene 
chloride and, thus, required a greater amount of methanol 
to precipitate from the polymer solution. The PLGA 
polymer of a relatively high L/G ratio (75/25) had a higher 
solubility in methylene chloride than the other PLGA 
(L/G ratio=50/50). A lower molecular weight polymer had 
a higher solubility in methylene chloride than a higher 
molecular weight polymer. End-capped polymers, which 
were more hydrophobic than non-end-capped polymers of 
the same molecular weight and component ratio, were 
more soluble in methylene chloride. Diffusion of drugs 
into the continuous phase mostly occurred during the first 
10 minutes of emulsification; therefore, as the time the 
polymer phase stayed in the non-solidified (semi-solid) 
state was extended, encapsulation efficiency became 
relatively low. In Mehta’s study, polymers having 
relatively high solubility in methylene chloride took 
longer to solidify and resulted in low encapsulation 
efficiencies, and vice versa7. Particle size and bulk density 
also varied according to the polymer. Since polymers 
having higher solubility in methylene chloride stayed 
longer in the semi-solid state, the dispersed phase became 
more concentrated before it completely solidified, 
resulting in denser microparticles. 
Selection of solvent system for the dispersed phase 
Selection of solvent system based on the volatility of 
solvent and solubility of polymer and type of method of 
preparation used for preparation of microspheres. Solvent 
should have high volatility and high polymer solubility. 
Jia Yu et al were used mixture of methanol and methylene 
chloride (1: 9) as the organic phase to increase the 
solubility of the drug. In this process, an increase was 
observed in the rate of precipitation of the polymer in the 
droplet–water interface; thus, the loss of drug into the 
outer aqueous phase was minimized, resulting in 
homogeneous and smaller particles 39.  
Bodmeier et al found that methylene chloride resulted in 
higher encapsulation efficiency as compared with 
chloroform or benzene, even though methylene chloride 
was a better solvent for poly (lactic acid) (PLA) than the 
others. Methylene chloride is more soluble in water than 
chloroform or benzene. The ‘high’ solubility allowed 
relatively fast mass-transfer between the dispersed and the 
continuous phases and led to fast precipitation of the 
polymer. The significance of solubility of the organic 
solvent in water was also confirmed by the fact that the 
addition of water-miscible co-solvents such as acetone, 
methanol, ethyl acetate, or dimethyl sulfoxide (DMSO), 
contributed to increase of the encapsulation efficiency 11. 
Knowing that the methanol is a non-solvent for PLA and a 
water-miscible solvent, it can be assumed that methanol 
played a dual function in facilitating the polymer 
precipitation: First, the presence of methanol in the 
dispersed phase decreased the polymer solubility in the 
dispersed phase 40. Second, as a water-miscible solvent, 
methanol facilitated diffusion of water into the dispersed 
phase. 
Park et al. were prepared lysozyme-loaded PLGA 
microparticles using the oil in water (o/w) single emulsion 
technique. Here, the authors used a co-solvent system, 
varying the ratio of the component solvents. DMSO was 
used for solubilization of lysozyme and PLGA, and 
methylene chloride was used for generation of emulsion 
drops as well as solubilization of PLGA. Encapsulation 
efficiency increased, and initial burst decreased as the 
volume fraction of DMSO in the co-solvent system 
increased. Particle size increased, and density of the 
microparticle matrix decreased with increasing DMSO. 
Overall, these results indicate that the presence of DMSO 
increased the hydrophilicity of the solvent system and 
allowed fast extraction of the solvent into the continuous 
phase, which led to higher encapsulation efficiency and 
larger particle size 41. 
Ratio of dispersed phase to continuous phase (D/C 
ratio):
 
No significant difference in particle size was observed (P 
> 0.05). All microspheres have a spherical shape without 
pores on the surface, with size approximately 20 µm. 
However, the drug loading and encapsulation efficiency 
Dhakar et al                                    Journal of Drug Delivery & Therapeutics; 2012, 2(6), 128-133   131 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
increased remarkably with decreasing D/C ratio (P < 0.05) 
42. Similar phenomena were reported for the encapsulation 
of progesterone 43. Additionally, the surface of 
microspheres was smoother at lower D/C ratios, probably 
due to the faster solidification rate. It has been reported 
that the porosity in a system of microspheres is 
determined during microspheres hardening as the organic 
solvent evaporates during preparation 43. Continuous 
phase containing a large amount of water resulted in faster 
polymer precipitation and therefore less porous spheres 
were formed 44. 
Encapsulation efficiency and particle size increase as the 
volume of the continuous phase increases in case of O/W 
emulsification method. For example, the encapsulation 
efficiency increased more than twice as the ratio of the 
dispersed phase to the continuous phase (DP/CP ratio) 
decreased from 1/50 to 1/3007-9. It is likely that a large 
volume of continuous phase provides a high concentration 
gradient of the organic solvent across the phase boundary 
by diluting the solvent, leading to fast solidification of the 
microparticles. Sah et al utilized ethyl acetate as a solvent 
in polymer solution for the formation of microparticles 
When 8 mL of PLGA solution (o) was poured into 50 mL 
of water phase (w), the polymer solution was well 
disintegrated into dispersed droplets. On the other hand, 
when the continuous phase was 80 mL or more, the 
microspheres hardened quickly and formed irregular 
precipitates. This is because the large volume of 
continuous phase provided nearly a sink condition for 
ethyl acetate and extracted the solvent instantly. Due to 
the fast solidification of the polymer, particle size 
increased with increasing volume of the continuous phase 
45  
As volume of continuous phase is increased, the size of 
microspheres decreased which results in decrease in 
loading efficiency, less mucoadhesion time and faster 
drug release. 14 
Interaction between drug and polymer: 
Interaction between protein and polymer contributes to 
increasing encapsulation efficiency 46. Generally, proteins 
are capable of ionic interactions and are better 
encapsulated within polymers that carry free carboxylic 
end groups than the end-capped polymers. On the other 
hand, if hydrophobic interaction is a dominant force 
between the protein and the polymer, relatively 
hydrophobic end-capped polymers are more advantageous 
in increasing encapsulation efficiency 7. In certain cases, a 
co-encapsulated excipient can mediate the interaction 
between protein and polymer 47. For example; 
encapsulation efficiency increased when gamma 
hydroxypropyl cyclodextrin (g-HPCD) were co-
encapsulated with tetanus toxoid in PLGA microparticles. 
It is supposed that the g-HPCD increased the interaction 
by accommodating amino acid side groups of the toxoid 
into its cavity and simultaneously interacting with PLGA 
through Van-der Waals and hydrogen bonding forces. 
Solubility of drug in continuous phase: 
If the drug is more soluble in continuous phase, more drug 
loss in the continuous phase is occurs due to diffusion of 
drug from dispersed phase to continuous phase. If the 
solubility of the drug in the continuous phase is higher 
than in the dispersed phase, the drug will easily diffuse 
into the continuous phase during this stage which tends to 
decrease the encapsulation efficiency. For example, the 
encapsulation efficiency of quinidine sulfate was 40 times 
higher in the alkaline continuous phase (pH 12, in which 
quinidine sulfate is insoluble) than in the neutral 
continuous phase (pH 7, in which quinidine sulfate is very 
soluble) 11. 
Effect of concentration of emulsifier: 
Thakkar et al investigated the effect of emulsifier on the 
size, encapsulation efficiency and drug entrapment of the 
microspheres prepared using a natural polymer (bovine 
serum albumin) BSA using emulsification chemical cross-
linking method. Results from this investigation shows that 
increase in concentration of Span-85 decrease the 
encapsulation efficiency of microspheres in some extent. 
This is due to fact that increase in Span-85 concentration 
leads to stabilization of small droplets and results in 
smaller microspheres. Loss of drug from surface of small 
microspheres is more as compared to larger microspheres 
during washing 16.  
Rawat et al studied the Influence of Selected Formulation 
Variables on the Preparation of Enzyme-entrapped 
Eudragit S100 Microspheres. Figure 4 represent the 
response surface plot, which shows the effects of the 
DCM and Tween80 on the drug loading of microspheres. 
Drug loading decreased as the concentration of DCM was 
increased 19. 
 
Fig 3: Effect of emulsifier (Tween 80) on the drug content 
of Microspheres 19 
Lakshmana Prabu S et al concluded that, amount of PVA 
as an emulsifying agent did not influence the drug loading 
and entrapment efficiency of microspheres however the 
particle size of microspheres is seen to be dependent on 
the PVA concentration in the continuous phase. The 
results revealed that on increasing PVA concentration, 
more PVA molecules may overlay the surface of the 
droplets, providing an increased protection of the droplets 
against coalescence resulting in the production of small 
emulsion droplets. Since microspheres were formed from 
emulsion droplets after solvent evaporation, their size was 
dependent on the size of emulsion droplets. 31 
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Effect concentration of cross linking agent: 
Patel et al has studied effect of cross linking agent on 
loading efficiency of mucoadhesive microspheres of 
glipzide. Result from this study showed significant effect 
on the percentage mucoadhesion and drug entrapment 
efficiency of microspheres. The higher amount of 
glutaraldehyde appears to favor the cross-linking reaction, 
and hence spherical free-flowing microspheres were 
obtained with an increase in loading efficiency 21. 
CONCLUSION:  
The purpose of this work was to understanding effect of 
various process as well as formulation variables on the 
encapsulation efficiency of the microspheres. This review 
will focus on how the formulation variables of 
microspheres formulation affect the drug entrapment 
efficiency the microspheres. This paper also explains that 
how drug entrapment efficiency depend upon particle size, 
Polymer concentration, type of polymer, drug: polymer 
ratio, DP: CP ratio, drug: polymer interaction, solubility of 
polymer as well as drug, method of preparation etc. The 
stirring rate of emulsion system, concentration of polymer, 
drug: polymer interactions, concentration of cross linkers 
are directly proportional to drug entrapment efficiency. 
Whereas higher drug to polymer ration, high 
concentration of emulsifier decrease the drug loading 
efficiency of microspheres. It is the reliable means to 
increase the loading efficiency, if optimize the 
formulation as well as process variables. This will only 
possible by understanding the effect of various variables 
which affect the drug entrapment efficiency of these 
microspheres. Among all the variables stirring speed, 
polymer concentration, solubility of drug and polymer and 
drug: polymer interactions are the variables which have 
significant effect on the drug entrapment efficiency. 
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